Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Johansson, Per ^a,b   Almqvist, Erik G ^c   Johansson, Jan Ove ^b   Mattsson, Niklas ^b,d   Andreasson, Ulf ^b   Hansson, Oskar ^e   Wallin, Anders ^b   Blennow, Kaj ^b   Zetterberg, Henrik ^b,f   Svensson, Johan ^b,c  

^a Department of Neuropsychiatry Skaraborg Central Hospital   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c CENTRAL HOSPITAL   (Sweden)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e LUND UNIVERSITY   (Sweden)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; APOLIPOPROTEIN E4; CALCIUM; CHOLINESTERASE; PARATHYROID HORMONE; TAU PROTEIN;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PROTEIN PHOSPHORYLATION; SEX DIFFERENCE; VITAMIN BLOOD LEVEL;

ACETYLCHOLINESTERASE; AGED; ALZHEIMER DISEASE; BUTYRYLCHOLINESTERASE; CALCIUM; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; VITAMIN D;

EID: 84896689839     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081989     Document Type: Article

References (44)

1. Shetty PK, Galeffi F, Turner DA (2011) Age-induced alterations in hippocampal function and metabolism. Aging DIS 2: 196-218. PubMed: 22081793.
2. Lu'o'ng K, Nguyên L (2011) The beneficial role of vitamin D in Alzheimer's disease. Am; Alzheimers J Dis Other Demen 26: 511-520.
3. Eyles DW, Feron F, Cui X, Kesby JP, Harms LH et al. (2009) Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology 34S: S247-S257. PubMed: 19500914.
4. Sutherland M, Somerville M, Yoong L, Bergeron C, Haussler M et al. (1992) Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain. Resour - Mol Brain Res 13: 239-250. doi:10.1016/0169-328X(92)90032-7.
5. Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW et al. (2001) Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 21: 98-108. PubMed: 11150325. (Pubitemid 32098731)
6. Eyles DW, Burne TH, McGrath JJ (2013) Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol 34: 47-64. doi:10.1016/j.yfrne.2012.07.001. PubMed: 22796576.
7. Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J et al. (2009) 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis 17: 703-717. PubMed: 19433889.
8. Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW et al. (2010) Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 74: 27-32. doi:10.1212/WNL. 0b013e3181d0ccb7. PubMed: 19794127.
9. Lehmann DJ, Refsum H, Warden DR, Medway C, Wilcock GK et al. (2011) The vitamin D receptor gene is associated with Alzheimer's disease. Neurosci Lett 504: 79-82. doi:10.1016/j.neulet.2011.08.057. PubMed: 21911036.
10. Balion C, Griffith LE, Strifler L, Henderson M, Patterson C et al. (2012) Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 79: 1397-1405. doi:10.1212/WNL.0b013e31826c197f. PubMed: 23008220.
11. Annweiler C, Llewellyn DJ, Beauchet O (2013) Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis 33: 659-674. PubMed: 23042216.
12. Pardridge WM, Sakiyama R, Coty WA (1985) Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier. J Neurochem 44: 1138-1141. doi:10.1111/j.1471-4159.1985.tb08735.x. PubMed: 3838342. (Pubitemid 15105766)
13. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT et al. (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215: 1237-1239. doi:10.1126/science.7058341. PubMed: 7058341. (Pubitemid 12106486)
14. Schliebs R, Arendt T (2011) The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221: 555-563. doi:10.1016/j.bbr.2010.11.058. PubMed: 21145918.
15. Perry EK, Perry RH, Blessed G, Tomlinson BE (1978) Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol 4: 273-277. doi:10.1111/j.1365-2990.1978.tb00545.x. PubMed: 703927. (Pubitemid 9001675)
16. Inestrosa N, Dinamarca M, Alvarez A (2008) Amyloid-cholinesterase interactions. Implications for Alzheimer'S Disease. FEBS J 275: 625-632. (Pubitemid 351160969)
17. Dinamarca MC, Sagal JP, Quintanilla RA, Godoy JA, Arrázola MS et al. (2010) Amyloid-beta-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Abeta peptide. Implications for the pathogenesis of Alzheimer's disease. Mol Neurodegener 5: 4. doi:10.1186/1750- 1326-5-4. PubMed: 20205793.
18. Chacón MA, Reyes AE, Inestrosa NC (2003) Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus. J Neurochem 87: 195-204. doi: 10.1046/j.1471-4159.2003. 01985.x. PubMed: 12969266. (Pubitemid 37210653)
19. Johansson P, Mattsson N, Hansson O, Wallin A, Johansson JO et al. (2011) Cerebrospinal fluid biomarkers for Alzheimer's disease: diagnostic performance in a homogeneous mono-center population. J Alzheimers Dis 24: 537-546. PubMed: 21297262.
20. McKhann G, Drachman D, Folstein M, Katzman R, Price D et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944. doi:10.1212/WNL.34.7.939. PubMed: 6610841. (Pubitemid 14076461)
21. Román G, Tatemichi T, Erkinjuntti T, Cummings J, Masdeu J et al. (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43. pp. 250-260. (Pubitemid 23060253)
22. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P et al. (2000) Research criteria for subcortical vascular dementia in clinical trials. Journal of Neural Transm Suppl 59: 23-30. (Pubitemid 30479402)
23. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256: 183-194. doi:10.1111/j.1365-2796.2004.01388.x. PubMed: 15324362.
24. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198. doi: 10.1016/0022-3956(75)90026-6. PubMed: 1202204.
25. Parnetti L, Chiasserini D, Andreasson U, Ohlson M, Hüls C et al. (2011) Changes in CSF acetyl- and butyrylcholinesterase activity after longterm treatment with AChE inhibitors in Alzheimer's disease. Acta Neurol Scand 124: 122-129. doi:10.1111/j.1600-0404.2010.01435.x. PubMed: 20880294.
26. Vanderstichele H, Van Kerschaver E, Hesse C, Davidsson P, Buyse MA et al. (2000) Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma. Amyloid 7: 245-258. doi: 10.3109/13506120009146438. PubMed: 11132093.
27. Blennow K, Wallin A, Agren H, Spenger C, Siegfried J et al. (1995) Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 26: 231-245. doi:10.1007/BF02815140. PubMed: 8748926. (Pubitemid 26002016)
28. Vanmechelen E, Vanderstichele H, Davidsson P, Van Kerschaver E, Van Der Perre B et al. (2000) Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett 285: 49-52. doi:10.1016/S0304-3940(00)01036-3. PubMed: 10788705. (Pubitemid 30224621)
29. Blennow K, Ricksten A, Prince JA, Brookes AJ, Emahazion T et al. (2000) No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression. J Neural Transm 107: 1065-1079. doi: 10.1007/s007020070052. PubMed: 11041282.
30. Darreh-Shori T, Siawesh M, Mousavi M, Andreasen N, Nordberg A (2012) Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease. J Alzheimers Dis 28: 443-458. PubMed: 22012848.
31. Balabanova S, Richter HP, Antoniadis G, Homoki J, Kremmer N et al. (1984) 25-Hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human cerebrospinal fluid. Klin Wochenschr 62: 1086-1090. doi:10.1007/ BF01711378. PubMed: 6334780. (Pubitemid 15202112)
32. Holmøy T, Moen SM, Gundersen TA, Holick MF, Fainardi E et al. (2009) 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult Scler 15: 1280-1285. doi: 10.1177/1352458509107008. PubMed: 19808741.
33. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96: 1911-1930. doi:10.1210/jc.2011-0385. PubMed: 21646368.
34. Annweiler C, Fantino B, Schott AM, Krolak-Salmon P, Allali G et al. (2012) Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. Eur J Neurol 19: 1023-1029. doi:10.1111/j.1468-1331.2012.03675.x. PubMed: 22339714.
35. Atack JR, May C, Kaye JA, Kay AD, Rapoport SI (1988) Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type. Ann Neurol 23: 161-167. doi:10.1002/ana.410230736. PubMed: 3377438. (Pubitemid 18081454)
36. Appleyard ME, Smith AD, Berman P, Wilcock GK, Esiri MM et al. (1987) Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Brain 110: 1309-1322. doi:10.1093/brain/110.5.1309. PubMed: 3676702. (Pubitemid 17168005)
37. Atack J (1989) Cerebrospinal fluid neurochemical markers in Alzheimer's disease. In F BollerR KatzmanA RascolJL SignoretY Cristen, Biological markers of Alzheimer's disease. Springer-Verlag Berlin. pp. 1-16.
38. Wallin A, Sjögren M, Blennow K, Davidsson P (2003) Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementia. Dement Geriatr Cogn Disord 16: 200-207. doi:10.1159/ 000072803. PubMed: 14512714. (Pubitemid 37203391)
39. Lehmann D, Johnston C, Smith A (1997) Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed. Journal of Alzheimer'S Disease - Hum Mol Genet 6: 1933-1936. (Pubitemid 27460370)
40. Kehoe PG, Williams H, Holmans P, Wilcock G, Cairns NJ et al. (1998) The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease. J Med Genet 35: 1034-1035. doi:10.1136/jmg.35.12.1034. PubMed: 9863603. (Pubitemid 28534679)
41. McIlroy SP, Crawford VL, Dynan KB, McGleenon BM, Vahidassr MD et al. (2000) Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland. J Med Genet 37: 182-185. doi:10.1136/jmg.37.3.182. PubMed: 10699053. (Pubitemid 30245911)
42. Shah I, Petroczi A, Tabet N, Klugman A, Isaac M et al. (2012) Low 25OH vitamin D2 levels found in untreated Alzheimer's patients, compared to acetylcholinesterase-inhibitor treated and controls. Curr Alzheimer Res 9: 1069-1076. doi:10.2174/156720512803568975. PubMed: 22876849.
43. Annweiler C, Fantino B, Gautier J, Beaudenon M, Thiery S et al. (2012) Cognitive effects of vitamin D supplementation in older outpatients visiting a memory clinic: a pre-post study. J Am Geriatr Soc 60: 793-795. doi:10.1111/j.1532-5415.2011.03877.x. PubMed: 22494292.
44. Annweiler C, Herrmann FR, Fantino B, Brugg B, Beauchet O (2012) Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: a pre-post pilot study. Cogn Behav Neurol 25: 121-127. doi:10.1097/WNN.0b013e31826df647. PubMed: 22960436.